The present invention relates to transfected primary and secondary somatic cells of vertebrate origin, particularly mammalian origin, transfected with exogenous genetic material (DNA) which encodes erythropoietin or an insulinotropin [e.g., derivatives of glucagon-like peptide 1(GLP-1)], methods by which primary and secondary cells are transfected to include exogenous genetic material encoding erythropoietin or an insulinotropin, methods of producing clonal cell strains or heterogenous cell strains which express eruthropoietin or an insulinotropin, methods of gene therapy in which the transfected primary or secondary cells are used, and methods of producing antibodies using the transfected primary or secondary cells. The present invention includes primary and secondary somatic cells, such as fibroblasts, keratinocytes, epithelial cells, endothelial cells, glial cells, neural cells, formed elements of the blood, muscle cells, other somatic cells which can be cultured and somatic cell precursors, which have been transfected with exogenous DNA encoding EPO or an insulinotropin, which is stably integrated into their genomes or is expressed in the cells episomally.

A invenção atual relaciona-se a transfected preliminar e as pilhas somatic secundárias da origem vertebrate, particularmente origem mammalian, transfected com material genetic exogenous (DNA) que codifica o erythropoietin ou um insulinotropin [ por exemplo, derivatives glucagon-como do peptide 1(GLP-1) ], os métodos por que as pilhas preliminares e secundárias são transfected para incluir o erythropoietin codificando material genetic exogenous ou um insulinotropin, métodos de produzir tensões clonal da pilha ou as tensões heterogenous da pilha que eruthropoietin expresso ou um insulinotropin, os métodos da terapia do gene em que transfected preliminar ou as pilhas secundárias são usadas, e os métodos de produzir usar-se dos antibodies transfected pilhas preliminares ou secundárias. A invenção atual inclui pilhas somatic preliminares e secundárias, tais como fibroblasts, keratinocytes, pilhas epithelial, pilhas endothelial, pilhas glial, pilhas neural, elementos dados forma do sangue, pilhas do músculo, outras pilhas somatic que podem ser cultivadas e os precursors da pilha somatic, que foram transfected com o DNA exogenous que codifica o EPO ou um insulinotropin, que é integrada estàvel em seus genomes ou expressada nas pilhas episomally.

 
Web www.patentalert.com

< GLP-1 as a diagnostic test to determine .beta.-cell function and the presence of the condition of IGT and type II diabetes

< Method for the improvement of islet signaling in diabetes mellitus and for its prevention

> Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity

> Method of acylating peptides and novel acylating agents

~ 00029